Lincoln Pharmaceuticals Limited — Others, 26-03-2025: Trading Window

Lincoln Pharmaceuticals has announced a board meeting to approve the audited financial results for the quarter and year ended March 31, 2025. In conjunction, the trading window for the company's securities will be closed from April 1, 2025, until 48 hours post-results declaration. This move aligns with best practices in insider trading and emphasizes the company's commitment to transparency. Investors may see this as a standard procedure; however, the closure could signal potential volatility depending on upcoming financial performance, prompting shareholders to stay informed about the results.